Biotech · Private company
Iterion Therapeutics
Track this companyFree. Adds Iterion Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials54 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- CabozantinibPhase 2 · Advanced Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- LenvatinibPhase 2 · Advanced Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TegavivintPhase 2 · Advanced Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TegavivintPhase 1 · Desmoid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular CarcinomaPHASE1_PHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07878689 · fetched Nov 12, 2026
- Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal CarcinomaPHASE1_PHASE2 · RECRUITING · started Feb 17, 2026ClinicalTrials.gov NCT07463599 · fetched Nov 12, 2026
- Tegavivint With Gemcitabine in Patients With Relapsed or Refractory OsteosarcomaPHASE1 · RECRUITING · started Jan 22, 2026ClinicalTrials.gov NCT07144254 · fetched Nov 12, 2026
- A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular CarcinomaPHASE1_PHASE2 · RECRUITING · started Sep 13, 2023ClinicalTrials.gov NCT05797805 · fetched Nov 12, 2026
- Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059PHASE1 · COMPLETED · started Jul 15, 2018ClinicalTrials.gov NCT03459469 · fetched Nov 12, 2026